Patents by Inventor Grant Ganshaw

Grant Ganshaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising bowman-birk protease inhibitors and variants thereof
    Patent number: 7696173
    Abstract: The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.
    Type: Grant
    Filed: July 14, 2008
    Date of Patent: April 13, 2010
    Assignee: Danisco US Inc.
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • COMPOSITIONS COMPRISING BOWMAN-BIRK PROTEASE INHIBITORS AND VARIANTS THEREOF
    Publication number: 20090111160
    Abstract: The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.
    Type: Application
    Filed: July 14, 2008
    Publication date: April 30, 2009
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • Bacterial expression of bowman-birk protease inhibitors and variants thereof
    Patent number: 7413877
    Abstract: The present invention provides compositions and methods related to the expression of Bowman-Birk protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the Bowman-Birk protease inhibitors.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: August 19, 2008
    Assignee: Genencor International, Inc.
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • Mass spectrometric analysis of biopolymers
    Publication number: 20050244848
    Abstract: The present invention makes use of unique tags of a specific biopolymer that can be exploited for determining the concentration the biopolymer in crude solutions. In preferred embodiments the biopolymer is either a protein or a polynucleotide. Particularly, the invention provides a method for the determination and quantitation of biomolecules in crude mixtures by way of a separation technique in combination with mass spectroscopy. In one general embodiment, a target biomolecule is selected for analysis and an analog thereof is generated. Peak area integration of the peptide pairs provides a direct measure for the amount of target protein in the crude solution.
    Type: Application
    Filed: December 14, 2004
    Publication date: November 3, 2005
    Inventors: David Estell, Grant Ganshaw, Christian Paech, Sigrid Paech
  • Proteins producing an altered immunogenic response and methods of making and using the same
    Publication number: 20050202551
    Abstract: The present invention relates to novel protein variants that exhibit reduced allergenicity when compared to the parental proteins. Also included are DNA molecules that encode the novel variants, host cells comprising the DNA and methods of making proteins less allergenic.
    Type: Application
    Filed: May 12, 2005
    Publication date: September 15, 2005
    Inventors: David Estell, Grant Ganshaw, Fiona Harding, Edmund Larenas, Ayrookaran Poulose, Elizabeth Sikorski, Elliott Russell
  • Proteins producing an altered immunogenic response and methods of making and using the same
    Publication number: 20050202552
    Abstract: The present invention relates to novel protein variants that exhibit reduced allergenicity when compared to the parental proteins. Also included are DNA molecules that encode the novel variants, host cells comprising the DNA and methods of making proteins less allergenic.
    Type: Application
    Filed: May 12, 2005
    Publication date: September 15, 2005
    Inventors: David Estell, Grant Ganshaw, Fiona Harding, Edmund Larenas, Ayrookaran Poulose, Elizabeth Sikorski, Elliott Russell
  • Bacterial expression of protease inhibitors and variants thereof
    Publication number: 20050202535
    Abstract: The present invention provides compositions and methods related to expression of protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the protease inhibitors.
    Type: Application
    Filed: November 8, 2004
    Publication date: September 15, 2005
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell